The development of pharmacological substances, capable of exerting powerful effects at known sites in the nervous system, has provided a new versatile tool for clinical research. No longer is it necessary to destroy a part of the nervous system in order to study what effect it may have upon a phenomenon; the activity of that part may be held in abeyance by the use of pharmacological blocking agents. Likewise, stimulation no longer always demands the application of electrodes; drugs acting at a specific site provide a more elegant experiment. But the supreme advantage is that these methods can be applied to man, thus eliminating the many pitfalls which arise when human problems are studied in other species.
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The aggravation of Parkinsonian tremor which occurs when a patient becomes emotionally upset has long been attributed to the release of adrenaline, and Barcroft, Peterson, and Schwab (1952) have shown that the infusion of adrenaline into patients suffering from Parkinsonism increases their tremor. These workers had not, however, the means at their disposal of ascertaining the site of action of the adrenaline. There is evidence that adrenaline can act at several sites in the nervous system. Thus, Marazzi (1960) has shown that adrenaline may cause inhibition at cortical synapses, and McLennan (1961) found that catechol amines, when applied to the exposed spinal cord of the cat, inhibit the knee jerk.
The present study was carried out to ascertain the site at which catechol amines act in aggravating Parkinsonian tremor.
METHOD
Tremors were recorded by means of a valve, sensitive to acceleration, which the patient, while sitting comfortably in a chair, held in the outstretched hand. The output of the valve upset the balance of a bridge circuit and after amplification was recorded by a pen-writer on moving paper. The apparatus was fully described by Marshall and Walsh (1956 The amplitude of the tremor was greatly increased in all the patients except one (Fig. 1) . The increase became evident three to five minutes after the injection, reaching a peak in eight to 10 minutes and persisting for 20 to 25 minutes. The degree of increase in the amplitude is shown in Table I . each of 1 sec. duration. The resting tremor of the above patients was 4 to 6 c/s. In four (three males and one female) the frequency was increased by 1 to 2 c/s, in three (one male and two females) by 2 to 3 c/s, and in one (female) by 3 to 4 c/s (Fig. 2) . Again in women there was a tendency for a greater increase in the frequency of the tremor than in men.
In three patients (two males and one female) adrenaline, diluted in isotonic saline, was given by intravenous infusion at a rate of 20 ,ug. per minute. The increase of tremor was observed 45 seconds after the beginning of the infusion and there was no significant difference in the increase in the amplitude of the tremor from that observed after intramuscular administration (Fig. 3) .
THE EFFECT OF SALINE In order to exclude the possibility that apprehension of the experimental situation was causing the increase in amplitude of the tremor, the injection of adrenaline was preceded by an intramuscular injection of sterile normal saline in 10 of the patients. This produced no change in the amplitude or frequency of the tremor (Fig. 4) , except in one instance where there was a negligible increase in amplitude of less than 20%.
EFFECT OF PRECEDING MEDICATION Five patients were given anti-Parkinsonian drugs before the administration of adrenaline. They received Artane, 2 mg. q.d.s., for the preceding 24 hours. The increase in the amplitude of the tremor caused by the adrenaline was less than it had been when recorded without premedication (Table II and (Fig. 6) Adrenaline was administered in five patients into the brachial artery proximal to the elbow over the point of the maximal pulsation in the antecubital fossa. A sphygmomanometer cuff inflated to above diastolic blood pressure was in position above the site of injection.
In one subject adrenaline was infused at a rate of 10 ,ug. per minute. In four subjects adrenaline was administered by an acute intra-arterial injection in a dose of 0 1 to 0-3 mg. Within a minute marked pallor was observed starting in the fingers and spreading to the hand, and once up to the elbow. This was particularly marked with larger amounts (more than 0-1 mg.). Marked coldness was noticed also. The radial pulse became smaller whereas the pulse in the other arm remained the same. The local reaction reached its peak in two to three minutes and then gradually subsided over the next 10 minutes. With doses up to 0 I mg. no change in the pulse or c blood pressure was observed, but with larger doses (0-2 to 03 mg.) there was a little increase in the blood pressure and the pulse rate. In no case was there any increase in the tremor. There was, however, a slight increase in amplitude after the cuff of the sphygmomanometer was released. An intramuscular injection of 0 3 mg. adrenaline in these patients produced the expected increase in the amplitude and frequency of the tremor (Fig. 8) .
ACTION OF ADRENALINE AFTER ADMINISTRATION OF GANGLION-BLOCKING DRUGS (HEXAMETHONIUM) In
five patients 1 mg. of adrenaline was injected intramuscularly and the usual increase in the tremor was observed. Forty-five minutes after the injection, by which time the tremor had reverted to normal, an intravenous infusion of normal saline was begun with the patient lying comfortably. After the second administration of adrenaline the blood pressure rose to the previous levels, and then increased by a further 15 %. There was no significant difference in the increase of the adrenaline-induced tremor before and after the administration of the hexamethonium (Fig. 9) recorded. Forty-five minutes later phentolamine was given intravenously in doses varying from 5 to 15 mg. The injection of adrenaline was repeated intramuscularly at the same dosage (1 mg.) five to 10 minutes after the phentolamine injection. There was no change in the adrenaline-induced tremor before and after the phentolamine (Fig. 10) .
EFFECT OF ADRENALINE BEFORE AND AFTER ADMINIS-TRATION OF DRUGS ACTING ON POSTGANGLIONIC SYMPATHETIC NERVE FIBRES These drugs selectively block transmission in the postganglionic sympathetic nerve fibres and prevent the release of the transmitter substance at the termination of the nerve fibre. They do not antagonize the action of injected adrenaline on the effector organ. Guanethidine was given to four patients in doses of 30 mg. daily for a week. There was again no change in the effect of adrenaline on the tremor before and after the administration of this drug (Fig. 11 ).
DISCUSSION
These experiments have shown that adrenaline, and to a lesser extent isoprenaline, caused a marked increase in the amplitude of the tremor of Parkinsonism. This increase was clearly due to the pharmacological action of adrenaline, and not to general apprehension, since the injection of saline produced no effect. Noradrenaline, on the other hand, did not increase the amplitude or frequency of Parkinsonian tremor. This is in keeping with the findings of Barcroft, Peterson, and Schwab (1952) , who observed that intravenous infusion of adrenaline caused an increase in tremor in 50 % of their patients, whereas noradrenaline had no effect. The increase in the amplitude of the tremor in the present series was up to 400 % and in frequency up to 30 %. These increases were remarkably constant; administration of the same amount of adrenaline to the same patients on different days had the same effects.
The site of action of the adrenaline was indicated by several experiments. First, the adrenaline administered intra-arterially had no effect on the tremor, whereas the same amount given intramuscularly produced a definite increase. This immediately suggested a central rather than a peripheral action. This suggestion was confirmed by more definitive experiments. The sympathetic ganglia were excluded as the site of action of the adrenaline by the absence of any change in its effect on tremor following the administration of ganglioplegic drugs (hexamethonium). Similarly, the postganglionic sympathetic fibre was eliminated by the administration of guanethidine which probably acts at this site. This likewise had no effect on adrenalineinduced tremor. The exclusion of a more peripheral action of adrenaline on effector cells was tried by the administration of phentolamine. No change in the adrenaline-produced tremor was observed after the administration of this agent, and therefore the action of adrenaline is clearly not at this site. In each of these experiments there was ample evidence that an adequate dose of the drug was being used, as the blood pressure was reduced in all the subjects even in the supine position.
The inhalation of isoprenaline in five subjects also produced an increase in tremor, but to a lesser degree than that produced by adrenaline. Tremor has in fact been reported as a side effect in the therapeutic use of isoprenaline (Gay and Long, 1949) . The action of this catechol amine resembles more closely the action of adrenaline than of noradrenaline. It is present in very small amounts in the adrenal cortex and has a stimulant action on the central nervous system (Goodman and Gilman, 1955; Laurence and Moulton, 1960) , hence may be affecting the same mechanism as does adrenaline.
Since the above experiments suggest no peripheral action of adrenaline, we must postulate a central action. The question arises as to its site, and why noradrenaline has no similar effect. There is considerable experimental evidence that adrenaline acts upon the brain-stem and particularly on the mesencephalic reticular formation. Bonvallet, Dell, and Hiebel (1954) showed that fluctuations in the electrical activity of the cortex paralleled those in sympathetic tone, and that adrenaline produced cortical activity, an effect which was abolished by intercollicular section of the brain-stem. They suggested, therefore, that circulating adrenaline activates the cortex through the postmesencephalic reticular formation. Rothballer (1956) also found that adrenaline in doses of 2 to 8 ,tg./kg. produced alternating phases of activation and deactivation in the E.E.G. of unanaesthetized cats, and that coagulation of the junction of the mesencephalon and diencephalon abolished this response. They observed similar effects with noradrenaline, however. De Maar and Martin (1956) also observed E.E.G. activation with adrenaline but in contrast to Rothballer, they failed to secure any response from noradrenaline. Rothballer (1957) also observed that the local injection of adrenalineinto the mid-brain reticular formation by a stereotactic method activated the E.E.G., an effect which was not obtained by injection into other sites. Dell, Bonvallet, and Hugelin (1954) observed facilitation of spinal reflexes following intravenous adrenaline, an effect which was abolished by a retromamillary section of the brain-stem. It seems clear that adrenaline acts on the brain-stem reticular
